Imunon (IMNN) Accumulated Depreciation (2012 - 2025)
Imunon's (IMNN) quarterly Accumulated Depreciation came in at $1.3 million in Q4 2025, up 6.66% YoY from $1.2 million in Q4 2024, and up 6.66% on a QoQ basis from $1.2 million in Q4 2024.
Imunon (IMNN) Accumulated Depreciation (2012 - 2025) Analysis & Trends
Imunon (IMNN) has 13 years of Accumulated Depreciation data on file, last reported at $1.3 million in Q4 2025.
- Quarterly Accumulated Depreciation rose 6.66% year-over-year to $1.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.3 million (up 6.66% YoY) and the FY2025 annual result came in at $1.3 million, up 6.66% from the prior year.
- Accumulated Depreciation improved to $1.3 million in Q4 2025, from $1.2 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $3.4 million in Q4 2021 to a low of $1.2 million in Q4 2024.
- A 5-year average of $2.1 million and a median of $2.1 million in 2023 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2024 — Accumulated Depreciation plunged 43.1% — and 2025, when it rose 6.66%.
- Tracing IMNN's Accumulated Depreciation over 5 years: stood at $3.4 million in 2021, then fell by 21.22% to $2.6 million in 2022, then retreated by 20.48% to $2.1 million in 2023, then sank by 43.1% to $1.2 million in 2024, then climbed by 6.66% to $1.3 million in 2025.
- The last three Accumulated Depreciation figures came in at $1.3 million (Q4 2025), $1.2 million (Q4 2024), and $2.1 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Dec 31, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 3.36 Mn |
| Dec 31, 2020 | 3.23 Mn |
| Dec 31, 2019 | 3.10 Mn |
| Dec 31, 2018 | 2.97 Mn |
| Dec 31, 2017 | 2.84 Mn |
| Dec 31, 2016 | 2.51 Mn |
| Dec 31, 2015 | 2.06 Mn |
| Dec 31, 2013 | 1.26 Mn |
| Dec 31, 2012 | 924,961.00 |